CG
EDVA

Cutler Group’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Cutler Group’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-65
Closed -$9K – 4590
2022
Q4 		$9K Buy
+65
New +$11.4K ﹤0.01% 2785

Other funds holding EDVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return

Cutler Group's EDVA Position: Q1 2023 in Review

Cutler Group sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2023, closing a stake of 65 shares — an estimated $9K sold.

Cutler Group first reported a position in EDVA in Q4 2022 and held it in 1 quarter. The position peaked at $9K in Q4 2022. 20 funds tracked by Wall St. Rank hold EDVA as of Q1 2023.

  • Cutler Group reported no remaining Endovia Health Sciences, Inc. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 65 Endovia Health Sciences, Inc. shares in Q1 2023, an estimated $9K.
  • Cutler Group first reported a position in Endovia Health Sciences, Inc. in Q4 2022 and held it in 1 quarter.
  • Cutler Group's Endovia Health Sciences, Inc. position peaked at $9K in Q4 2022.
  • 20 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.